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1. Abstract 
Introduction: Canine leishmaniosis (CanL) due to Leishmania infantum is a zoonotic 
protozoan disease endemic in Spain, where other vector-borne pathogens are quite 
common (Rickettsia conorii, Ehrlichia canis, Anaplasma spp, Hepatozoon canis, 
Babesia spp). Dogs are considered the main peridomestic reservoir for L. infantum 
infection and its clinical manifestation can vary from a total absence of clinical signs 
and clinicopathological abnormalities to a severe fatal clinical illness. Furthermore, 
there is evidence that other vector-borne organisms might affect the severity of CanL or 
mimic its clinical signs and/or clinicopathological abnormalities. The aim of this study 
was to determine co-infections with other vector-borne pathogens based on serological 
and molecular techniques in dogs with clinical leishmaniosis living in the 
Mediterranean basin and to associate them with clinical signs and clinicopathological 
abnormalities as well as disease severity. 
Materials and methods: Sixty-two dogs with clinical leishmaniosis and sixteen 
apparently healthy dogs were tested for Rickettsia conorii, Ehrlichia canis and 
Anaplasma phagocytophilum by the immunofluorescence antibody test (IFAT) and for 
Ehrlichia canis, Anaplasma spp, Hepatozoon spp. and Babesia spp. by polymerase 
chain reaction (PCR). 
Results: Among the dogs examined by IFAT, the seroprevalences were: 69.3% for R. 
conorii, 57.3% for E. canis and 44.0% for A. phagocytophilum; while the prevalences 
found by PCR were: 7.9% for E. canis/Anaplasma, 2.6% for Anaplasma platys and 
1.3% for H. canis. Statistical association was found between dogs with clinical 
leishmaniosis and seroreactivity to R. conorii antigen (P = 0.025; OR = 4.09) and A. 
phagocytophilum antigen (P = 0.002; OR = 14.34) and being positive to more than one 
serological or molecular tests (co-infections) (P = 0.013) when compared with healthy 
dogs. Interestingly, a statistical association was found between the presence of R. 
conorii, E. canis and A. phagocytophilum antibodies in sick dogs and some 
clinicopathological abnormalities such as a decrease of albumin and albumin/globulin 
ratio associated to the presence of R. conorii, A. phagocytophilum and E. canis high 
antibody titers, and an increase in serum globulins associated to the presence of A. 
phagocytophilum and E. canis high antibody titers. Furthermore, seroreactivity with A. 
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phagocytophilum antigens was statistically associated with LeishVet clinical stages III 
and IV. 
Conclusion: This study demonstrates that dogs with clinical leishmaniosis from the 
Barcelona and Tarragona area have a higher rate of co-infections with other vector-
borne pathogens when compared with healthy controls. Furthermore, positivity to other 
vector-borne pathogens was associated with more pronounced clinicopathological 
abnormalities as well as disease severity with canine clinical leishmaniosis. 
Keywords: Canine leishmaniosis; Spain; Leishmania infantum; Rickettsia conorii; 
Ehrlichia canis; Anaplasma phagocytophilum; Anaplasma platys; Hepatozoon canis; 
Co-infection. 
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2. Introduction 
Canine leishmaniosis (CanL) is a zoonotic and infectious disease caused by the 
protozoan Leishmania infantum. Phlebotomus spp. sand flies are the only arthropods 
adapted to the biologic transmission of this parasite in Europe (Petrella et al. 2015). 
Dogs (Canis familiaris) are considered the main peridomestic reservoir of this parasite 
in endemic areas, and owning a dog infected by this parasite could be a risk factor for 
members of the household (Gavgani et al. 2002). CanL is endemic in the Mediterranean 
basin, where its prevalence can be as high as 67 per cent in selected populations 
(Solano-Gallego et al. 2001), but the prevalence of the clinical disease can be lower than 
10 per cent (Solano-Gallego et al. 2009). The most useful diagnosis of CanL includes 
serology by quantitative techniques and PCR, although the direct observation of 
amastigote forms of Leishmania spp. are also useful in the clinical setting (Solano-
Gallego et al. 2009; Zanette et al. 2014; Pennisi 2015). 
The clinical manifestation of CanL can vary from a total absence of clinical signs and 
clinicopathological abnormalities to a severe fatal clinical illness. The most common 
clinical signs are skin lesions, progressive weight loss, generalized lymphadenomegaly, 
muscular atrophy, exercise intolerance, decreased appetite, lethargy, splenomegaly, 
polyuria and polydipsia, ocular lesions, epistaxis, onychogryphosis, lameness, vomiting 
and diarrhea (Baneth et al. 2008; Solano-Gallego et al. 2009; Pennisi 2015). 
In Spain, other vector-borne diseases are quite common. Some studies have documented 
Ehrlichia canis (Roura et al. 2005; Solano-Gallego et al. 2006; Amusategui et al. 2008; 
Tabar et al. 2009; Couto et al. 2010; Miró et al. 2013), Anaplasma platys (Tabar et al. 
2009; Miró et al. 2013) and Rickettsia conorii (Solano-Gallego et al. 2006; Amusategui 
et al. 2008; Ortuño et al. 2009; Espejo et al. 2016) infections in dogs, which are 
intracellular Gram-negative bacteria that appear to be transmitted by Rhipicephalus 
sanguineus ticks (Beugnet and Marié 2009; Little 2010; Chomel 2011; Dantas-Torres et 
al. 2012; Solano-Gallego et al. 2015; Espejo et al. 2016). It has been reported that the 
prevalence of these vector-borne infections is higher in communal shelter dogs and dogs 
that live outdoors (Amusategui et al. 2008; Miró et al. 2013). These clinical 
characteristics of rickettsial disease in dogs can be similar to those caused by L. 
infantum. Anaplasma phagocytophilum (Solano-Gallego et al. 2006; Amusategui et al. 
2008; Couto et al. 2010; Miró et al. 2013) is another pathogen transmitted by Ixodes 
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ricinus ticks that can also infect dogs and humans causing acute febrile illness or 
transient subclinical infections (Doudier et al. 2010; Miró et al. 2013). Other protozoan 
pathogens such as Babesia vogeli (Tabar et al. 2009) and Hepatozoon canis (Tabar et al. 
2009) infect dogs in the Mediterranean basin and they are also transmitted by R. 
sanguineus ticks (Beugnet and Marié 2009; Chomel 2011; Dantas-Torres et al. 2012). 
It has been detected that infections with other vector-borne organisms can affect the 
severity of the disease or mimic its clinical signs and/or clinicopathological 
abnormalities (Tuttle et al. 2003; De Tommasi et al. 2013; Baneth et al. 2015). Some 
studies (Cringoli et al. 2002; Roura et al. 2005; Tabar et al. 2009; Cardinot et al. 2016) 
have described co-infection of L. infantum with other vector-borne disease in dogs that 
showed the typical signs of leishmaniosis. Other authors (Mekuzas et al. 2009; Couto et 
al. 2010; De Tommasi et al. 2013; Mylonakis et al. 2014) have demonstrated co-
infections of L. infantum with E. canis, A. phagocytophilum and Bartonella spp. in the 
Mediterranean area. Mekuzas et al. (2009) found that clinical signs were more frequent 
in dogs with dual infection than dogs with single infection. Roura et al. (2005) stated 
that simultaneous infection with 2 or more pathogens should be expected in dogs living 
in areas which are highly endemic for several vector-borne pathogens, in dogs 
maintained predominantly outdoors and dogs that have not been treated with 
ectoparacitides. 
We hypothesized that dogs with leishmaniosis living in the Mediterranean basin might 
be co-infected with other pathogens that could mimic the clinical signs and/or 
clinicopathological abnormalities or might influence the severity of the disease. 
The aim of this study was to determine co-infections with other vector-borne pathogens 
in dogs with clinical leishmaniosis living in the Mediterranean basin and to associate 
with clinical signs and clinicopathological abnormalities as well as with disease 
severity. These dogs were compared with healthy control dogs living in the same 
geographical area. 
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3. Materials and methods 
Dogs 
The dogs included in this study were from Catalonia (Spain), an area endemic for 
canine leishmaniosis and other vector-borne diseases. Sixty-two sick dogs were 
diagnosed with clinical leishmaniosis based on physical examination, a complete blood 
count (CBC) (System Siemens Advia 120), a biochemical profile including creatinine, 
urea, total proteins, alanine transaminase (ALT) and total cholesterol (Analyzer 
Olympus AU 400), urianalysis with urinary protein creatinine ratio, and serum 
electrophoresis, a medium or high antibody levels in a quantitative ELISA for the 
detection of L. infantum-specific antibodies and/or cytology or histology. The dogs were 
examined at different veterinary centers: 34 were from Fundació Hospital Clínic 
Veterinari (Bellaterra, Barcelona), 15 were from Hospital Ars Veterinaria (Barcelona, 
Barcelona), 7 were from Hospital Mediterrani Veterinaris (Reus, Tarragona) and 6 
were from Consultori Montsant (Falset, Tarragona). Furthermore, the dogs were 
classified according to the LeishVet clinical staging system (Solano-Gallego et al. 
2009). Blood real-time PCR (RT-PCR) was also performed in all of these dogs. 
Sixteen apparently healthy dogs, based on clinical history and physical examination, 
were also studied. All healthy dogs were also seronegative and blood RT-PCR negative 
for Leishmania. 
Samples 
Blood samples of all dogs were collected as described previously (Solano-Gallego et al. 
2016). Six millilitres of blood were collected from the respective dogs by jugular or 
metatarsian venipuncture for the routine laboratory tests described above. Blood was 
transferred immediately into different tubes: ethylenediaminetetraacetic acid (EDTA) 
tubes for hematology and molecular testing and plain serum tubes. Once collected, 
samples were left at 4ºC overnight and then frozen at minus 80ºC until further use. 
All dogs enrolled in the study were privately owned pets for whom client informed 
consent was obtained. Residual samples from blood EDTA tube and serum were used in 
this study; therefore, ethical approval was not required. All serum and whole blood 
extractions were performed between 2014 and 2016 and stored at minus 80ºC until use 
for this study. The samples were taken at the time of diagnosis. 
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Serological test 
Quantitative ELISA for the detection of L. infantum-specific antibodies
1
 
The in-house ELISA was performed on sera of all dogs studied as previously described 
(Solano-Gallego et al. 2014) with some modifications. The samples were diluted to 
1:800 in Phosphate buffered saline (PBS)-Tween containing 1% dry milk and incubated 
in L. infantum antigen-coated plates (20 µg/ml) for 1 h at 37ºC. Then, the plates were 
washed three times with PBS-Tween and once with PBS alone and incubated with 
Protein A conjugated to horseradish peroxidase (Thermo Scientific, dilution 1:30000) 
for 1 h at 37ºC. After that, the plates were washed again as described above. The plates 
were developed by adding the substrate solution o-phenylenediamine and substrate 
buffer (SIGMAFAST OPD, Sigma Aldrich). The reaction was stopped with 50 µl of 
2.5M H2SO4. Absorbance values were read at 492 nm by an automatic reader (ELISA 
Reader Anthos 2020). All plates included the serum from a sick dog with confirmed 
infection as positive control and serum from a healthy dog as a negative control and all 
samples were analysed in duplicate. The result was quantified as ELISA units (EU) 
related to a positive canine serum used as a calibrator and arbitrarily set at 100 EU. 
Two-fold serial dilution ELISA
2
 
All samples with an optical density (OD) equal or higher to three were studied using a 
two-fold serial dilution ELISA. Sera two-fold dilutions were started at 1:800 and 
continued for 9 to 11 further dilutions. All samples were analysed on the same day and 
in the same ELISA plate to avoid variability. The result was quantified as ELISA units 
(EU) related to a calibrator arbitrary set at 100 EU, with an OD value of one at the 
1:800 dilution. The mean values of the dilutions at which the optical density (OD) were 
close to one were chosen for the calculation of the positivity % using the following 
formula: (Sample OD/Calibrator OD) x 100 x dilution factor. Sera were classified as: 
very high positive, when having a positivity percentage equal or higher than 40000 EU; 
high positive, when having a positive percentage equal or higher than 9000 EU and less 
than 40000 EU; medium positive, when having a positivity percentage equal or higher 
than 500 EU and less than 9000 EU; low positive, when having a positivity percentage 
lower than 500 EU and equal or higher than 100 EU; very low positive, when having a 
                                                          
1
 Performed in a previous study (Solano-Gallego et al. 2016). 
2
 Performed in a previous study (Solano-Gallego et al. 2016). 
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positivity percentage lower than 100 EU and equal or higher than 35 EU. Sera with 
percentage lower than 35 EU were classified as negative. The cut-off was established at 
35 EU (mean + 4 SD of values from 80 dogs from non-endemic area) as previously 
described (Solano-Gallego et al. 2014). 
IFAT for Rickettsia conorii, Ehrlichia canis and Anaplasma phagocytophilum 
antigens
3
 
An indirect immunofluorescence assay for the detection of specific IgG antibody 
against R. conorii antigen (MegaFLUO® RICKETTSIA conorii, Diagnostik Megacor, 
Hörbranz, Austria) was performed on serum of all dogs studied. The samples were 
diluted to 1:64 with PBS and 20 µl of every serum dilution were applied per well. The 
slides were incubated for 30 min at 37ºC. After that, a washing procedure was 
performed. The slides were washed twice with PBS for 5 min and once with distilled 
water. After the washing procedure described, we dropped 15 µl of FLUO FITC anti-
dog IgG conjugate onto each used well. The slides were incubated for another 30 min at 
37ºC in the dark to protect the photosensitive conjugate. The washing procedure 
described above was repeated. After the second washing procedure, we added some 
drops of mounting medium on the cover slips and removed the possible bubbles. We 
evaluated the slides using a fluorescence microscope (Leica DM6000 B) at 400x 
magnification and compared each well to the fluorescence pattern seen in the positive 
and negative controls. All samples were examined by three persons (Álvarez, Alejandra; 
Baxarias, Marta; Colvin, Maria Elisa) to avoid errors of observation. Each person 
examined the samples and wrote if they observed a positive or negative result. To 
reduce bias, the observers did not know which samples were examined. After the three 
people examined all the samples, the results were shared with the others. If the results 
obtained were different, an average of three observations was made, so if two people 
observed a positive result and the third person a negative one, it was considered 
positive. All samples negative at 1:64 were considered negative and no further dilutions 
were done. 
Indirect immunofluorescence assays for the detection of specific IgG antibody against 
E. canis (MegaFLUO® EHRLICHIA canis, Diagnostik Megacor, Hörbranz, Austria) 
and A. phagocytophilum (MegaFLUO® Anaplasma phagocytophilum, Diagnostik 
                                                          
3
 Performed in this study by Alejandra Álvarez, Marta Baxarias and Maria Elisa Colvin. 
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Megacor, Hörbranz, Austria) were also performed. The same protocol explained in the 
previous paragraph was used in the E. canis IFAT and the A. phagocytophilum IFAT. 
The slides were also observed by three people to avoid errors of observation and all 
samples negative at 1:64 were considered negative and no further dilutions were done. 
Two-fold serial dilution of IFAT (Antibody titration)
4
 
All samples with a positive result were further investigated using a two-fold serial 
dilution IFAT. The samples were diluted to 1:128 and 1:256. The same IFAT protocol 
explained above was performed. All samples were analysed by three people on the same 
day and in the same slide to avoid variability using the same protocol explained before. 
If a high positive result was still observed, the samples were diluted to 1:512 for R. 
conorii, and to 1:512 and 1:1024 for E. canis and A. phagocytophilum using the same 
protocol. At this point, if the samples had not reached a dilution with a negative result, 
the samples were classified as a high positive for R. conorii (>1:512) or as a high 
positive for E. canis or A. phagocytophilum antigens (>1:1024). 
Blood DNA extraction and polymerase chain reaction (PCR) 
Blood DNA extraction and Leishmania real-time PCR
5
 
Both, blood DNA extraction and Leishmania real time PCR were performed as 
previously described (Montserrat-Sangrà et al. 2016; Solano-Gallego et al. 2016) in the 
samples from sick dogs with leishmaniosis and in samples from apparently healthy 
dogs. Total DNA was extracted from EDTA whole blood using the DNA Gene 
extraction kit (Sigma Aldrich) following the manufacturer’s instructions with slight 
modifications. Forty µl of proteinase K solution were added to all samples. Four 
hundred µl of whole blood were used for all the samples. The other steps were 
performed as described in the protocol. Blood from a clinically healthy non-infected 
dog was used as a control for DNA contamination in every DNA extraction performed. 
Real-time PCR (RT-PCR) was performed with an absolute quantification as previously 
described (Montserrat-Sangrà et al. 2016; Solano-Gallego et al. 2016). Briefly, PCR 
mix reaction was prepared with 4 µl of DNA, 10 µl of master mix (TaqMan® Fast 
                                                          
4
 Performed in this study by Alejandra Álvarez, Marta Baxarias and Maria Elisa Colvin. 
5
 Performed in a previous study (Solano-Gallego et al. 2016). 
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Advanced Master Mix, Life Technologies), 1 µl of Leishmania primers and probes 
[Eukaryotic 18S rRNA Endogenous Control (VIC™/MGB Probe, Primer Limited)] and 
5 µl of H2O. PCR reaction was performed in duplicates for each sample and for each 
target gene. 
In order to verify that the PCR was done successfully, a positive control for Leishmania, 
a negative control from non-infected clinically healthy dog and a blank (well without 
DNA sample) were included in all the plates. PCR was carried out in a QuantStudio 
Flex™ 7 Real-Time PCR system (Life Technologies). Thermal cycling profile consisted 
of 50ºC for 2 min in order to activate the enzyme called amperase and 20 s at 95ºC 
followed by 40 cycles of 1 s at 95ºC and 20 s at 60ºC (Montserrat-Sangrà et al. 2016; 
Solano-Gallego et al. 2016). 
Absolute quantification was carried out by the interpolation of the unknown samples to 
the standard curve generated from a negative sample spiked with different quantities of 
Leishmania promastigotes. Depending on the value of parasitic load, the samples were 
classified as negative (0 parasites/ml), low positive (< 10 parasites/ml), medium positive 
(10-100 parasites/ml), high positive (100-1000 parasites/ml) or very high positive (< 
1000 parasites/ml) (Martínez et al. 2011). 
PCR for the detection of Ehrlichia canis and Anaplasma spp.
6
 
All samples were sent to the Koret School of Veterinary Medicine at the Hebrew 
University in Israel to be tested by PCR under the supervision of professor Gad Baneth. 
All samples were screened in duplicates for the presence of E. canis DNA using the 
real-time PCR assay as described below. A 123 base-pair (bp) segment of the 16S 
ribosomal RNA gene of E. canis was amplified using primers E.c 16S-fwd (5’-
TCGCTATTAGATGAGCCTACGT-3’) and E.c 16S-rev (5’-
GAGTCTGGACCGTATCTCAG-3’) as previously described (Peleg et al. 2010). The 
real-time PCR reaction was performed in a total volume of 20 µl containing 10 µl 
Maxima Hot Start PCR Master Mix (2X) (Thermo Scientific, Epsom, Surrey, UK), 0.6 
µl of 50 µM SYTO 9 solution (Invitrogen, Carlsbad, CA, USA), 1 µl of 8 µM solution 
of each primer, 5 µl of DNA and 2.4 µl sterile DNase/RNase-free water (Sigma, St. 
Louis, MO, USA), using the StepOnePlus real-time PCR thermal cycler (Applied 
                                                          
6
 This part of the study was performed at the Koret School of Veterinary Medicine of Hebrew University. 
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Biosystems, Foster City, CA, USA). Initial denaturation for 5 min at 95ºC was followed 
by 45 cycles of denaturation at 95ºC for 15 s, annealing and extension at 60ºC for 30 s, 
and final extension at 72ºC for 20 s. Amplicons were subsequently subjected to a melt 
step with the temperature being raised to 95ºC for 10 s and then lowered to 60ºC for 1 
min. The temperature was then raised to 95ºC at a rate of 0.3ºC/s. Amplification and 
melt profiles were analysed using the StepOnePlus software v2.2.2 (Applied 
Biosystems, Foster City, CA, USA). Samples were considered positive for E. canis 
DNA when the cycle threshold (Ct) values were in the range of 25-42 and the melting 
curves were identical to that of the positive control. 
Positive samples from this reaction were further analysed by conventional PCR using 
primers EHR16SD and EHR16SR which amplify a 345-bp fragment of the 16S rRNA 
gene of the genera Anaplasma and Ehrlichia (Parola et al. 2000). The PCR was 
performed in a total volume of 25 µl using PCR-ready High Specificity mix (Syntezza 
Bioscience, Jerusalem, Israel) with 500 nM of each primers and sterile DNase/RNase-
free water (Sigma, St. Louis, MO, USA). Amplification was performed using a 
programmable conventional thermocycler (Biometra, Göttingen, Germany). Initial 
denaturation was at 95ºC for 5 min, followed by 35 cycles of denaturation at 95ºC for 
30 s, annealing and extension at 55ºC for 30 s, and final extension at 72ºC for 30 s. 
After the last cycle, the extension step was continued for a further 5 min. PCR products 
were electrophoresed on 1.5% agarose gels stained with ethidium bromide and checked 
under UV light for the size of amplified fragments by comparison to a 100 bp DNA 
molecular weight marker. 
Negative and non-template controls (NTC) as well as the positive control were included 
in the reaction in duplicates. DNA from blood of a specific pathogen free (SPF) dog 
was used as a negative control. Non-template control reactions were done using the 
same procedure and reagents described above but without DNA added to the PCR 
reaction to rule out PCR contamination and nonspecific reactions. 
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PCR for the detection of Hepatozoon spp. and Babesia spp.
7
 
All samples were sent to the Koret School of Veterinary Medicine at the Hebrew 
University to be tested by PCR under the supervision of professor Gad Baneth. 
Molecular detection of Babesia spp. and Hepatozoon spp. was performed by screening 
all DNA samples by a conventional PCR assay targeting a 400 bp fragment of the 18S 
rRNA gene: Piroplasmid-F (3’-CCAGCAGCCGCGGTAATTC-5’) and Piroplasmid-R 
(3’-CTTTCGCAGTAGTTYGTCTTTAACAAATCT-5’) (Tabar et al. 2008). In order to 
identify cases of co-infection, positive samples were tested by additional PCRs using 
primers specifically designed for the detection of a fragment of the 18S rRNA gene of 
Babesia spp. (PIROA/PIROB) (Olmeda et al. 1997). DNA extracted from a dog 
infected with H. canis and from another dog infected with B. vogeli confirmed by PCR 
and sequencing were used as positive controls. 
Conventional PCR was performed in a total volume of 25 µl using the PCR-ready High 
Specificity mix (Syntezza Bioscience, Jerusalem, Israel) with 500 nM of each primers 
and sterile DNase/RNase-free water (Sigma, St. Louis, MO, USA). Amplification was 
performed using a programmable conventional thermocycler (Biometra, Göttingen, 
Germany). Initial denaturation at 95ºC for 5 min was followed by 35 cycles of 
denaturation at 95ºC for 30 s, annealing and extension at 64ºC for 30 s (for Piroplasmid-
F/Piroplasmid-R), 58ºC for 30 s (for PIROA/PIROB), and final extension at 72ºC for 30 
s. After the last cycle, the extension step was continued for a further 5 min. PCR 
products were electrophoresed on 1.5% agarose gels stained with ethidium bromide and 
evaluated under UV light for the size of amplified fragments by comparison to a 100 bp 
DNA molecular weight marker. Negative uninfected dog DNA, and non-template DNA 
controls were used in each run for all pathogens. 
Sequencing PCR products
8
 
Samples that were positive in PCR were purified using a PCR purification kit (Exo-
SAP; New England BioLabs, Inc., Ipswich, MA) and subsequently sequenced with 
sense and antisense primers using BigDye Terminator cycle sequencing chemistry by 
Applied Biosystems ABI 3700 DNA analyser (Sanger) and evaluated by the ABI’s data 
collection and sequence analysis software V5.4 (ABI, Carlsbad, CA) at The Center for 
                                                          
7
 This part of the study was performed at the Koret School of Veterinary Medicine of Hebrew University. 
8
 This part of the study was performed at the Koret School of Veterinary Medicine of Hebrew University. 
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Genomic Technologies (The Hebrew University, Jerusalem). Further analyses were 
done by the Chromas (V2.6) (www.technelysium.com.au; technelysium pty, Woollahra, 
Australia) and MEGA6 (Tamura et al. 2013) softwares. Clean Sequences were 
compared to other sequences deposited in GenBank® using NCBI Blastn software 
(National Center for Biotechnology Information, Bethesda, MD, USA). Only sequences 
with identity between 97%-100% and coverage above 99% were considered as positive 
for an organism. 
Statistical analysis 
A descriptive study of the detection of antibodies, the number of co-infections detected 
in each dog (depending on the results of the IFATs and PCRs performed) and the level 
of antibodies detected for the different pathogens was performed, and the medians were 
compared using a Mann-Whitney U test, a chi square test or a Fisher’s exact test 
depending on the distribution, the type of variable (quantitative or qualitative) and the 
number of samples. Shapiro-Wilk test was performed to detect the normality of the 
distribution of the samples. Spearman’s correlation was used to associate the number of 
co-infections and the clinical data of dogs that consisted on CBC, biochemical profile 
including creatinine, urea, total proteins, ALT and total cholesterol, urianalysis with 
urinary protein creatinine ratio, and serum electrophoresis, the antibody levels in a 
quantitative ELISA for the detection of L. infantum-specific antibodies and the result for 
Leishmania real time PCR. Logistic regression and Kruskal-Wallis test were also used 
to associate the detection of antibodies, the number of co-infections and the level of 
antibodies detected for the different pathogens with sex, age and season at time of 
diagnosis and the clinical data of dogs. A P-value < 0.05 was considered statistically 
significant. The statistical analysis was performed using the R program i386 version 
3.3.1 (https://www.r-project.org/) and the DeduceR program version 1.7-16 
(http://www.deducer.org) for Windows software. 
 
4. Results 
Signalment and clinical data 
Both sexes were represented in the sick group with 37 males (59.7%) and 25 females 
(40.3%). Forty-two out of 62 were intact, 30 males and 12 females. The median of age 
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at diagnosis was 5 years with a range from 5 months to 13 years. Forty-one were 
purebred (66%) and 21 were classified as mixed breed (34%); the most frequent 
purebreds were German shepherd (n=5; 8.1%), Boxer (n=4; 6.5%), Labrador retriever 
(n=3; 4.8%), French bulldog (n=3; 4.8%), Golden retriever (n=2; 3.2%), Dachshund 
(n=2; 3.2%), Doberman (n=2; 3.2%), American Staffordshire terrier (n=2; 3.2%) and 
Breton (n=2; 3.2%). Other breeds were represented only once. 
Fifty-nine of the 62 dogs were classified in different stages of leishmaniosis. Five 
(8.5%) were classified in stage I with mild disease, 41 (69.5%) were classified in stage 
II with moderate disease (29 classified in substage IIa and 12 classified in substage IIb), 
9 (15.2%) were classified in stage III with severe disease and 4 (6.8%) were in stage IV 
with very severe disease. 
Both sexes were also represented in the healthy group with 5 males (31.2%) and 6 
females (37.5%). Gender was not recorded in 5 dogs (31.2%). The median of age at 
diagnosis was 7 years with a range from 15 months to 13 years. Seven were purebred 
(43.4%) and 4 were classified as mixed breed. Breed was not recorded in 5 dogs. All 
recorded breeds were represented only once. 
No statistical differences were found between sick and apparently healthy dogs. 
IFAT 
The results of IFAT for R. conorii, E. canis and A. phagocytophilum antigens in sick 
and healthy dogs studied as well as molecular results are shown in the Table 1. Of the 
total 75 assessed by IFAT, 22 (29.3%) seroreacted with the three pathogens, 18 (24%) 
seroreacted with two of the pathogens screened and 26 (34.5%) seroreacted with at least 
one pathogen. Serum from 9 (12%) of the tested dogs did not react to any IFAT test 
performed. The most frequent seropositive serology were for R. conorii (52/75; 69.3%), 
followed by E. canis (43/75; 57.3%) and A. phagocytophilum (33/75; 44%) antigens. 
Fifty-six of the 61 (91.8%) dogs with clinical leishmaniosis had a positive result to at 
least one of the IFAT tests performed while 10 of the 14 (71.4%) dogs in the healthy 
group had also a positive result. No statistical difference was found when comparing the 
two groups of dogs (P = 0.057). As shown in Table 1, the most frequent seropositivity 
in dogs with clinical leishmaniosis were for R. conorii while E. canis antibodies were 
the most frequent in the healthy group. 
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Dogs with clinical leishmaniosis were more likely to have a positive result to more than 
one test (IFAT and PCR) (P = 0.013) (Fig. 1), to be seroreactive to R. conorii (P = 
0.025; OR = 4.09) and to A. phagocytophilum (P = 0.002; OR = 14.34) antigens (Table 
1) when compared with healthy dogs. No difference was found between seroreactivity 
to E. canis or being positive in the PCRs performed. 
 
Table 1 
Results of IFAT for R. conorii, E. canis and A. phagocytophilum antigens and PCR for E. canis, 
Anaplasma spp., Hepatozoon spp. and Babesia spp. in dogs with clinical leishmaniosis and healthy dogs. 
A comparison of the groups was made with Fisher’s exact test. 
 
Number (%, 95% CI) of seroreactive dogs 
IFAT test (antibody detection) 
Dogs with 
clinical 
leishmaniosis 
(n = 61) 
Healthy dogs 
(n = 14) 
Total dogs 
(n = 75) 
P-value 
R. conorii 46 (75.4, 64.5-86.2) 6 (42.9, 17.0-68.8) 52 (69.3, 58.9-79.7) 0.025 
E. canis 34 (55.7, 43.2-68.2) 9 (64.3, 39.2-89.4) 43 (57.3, 46.1-68.5) 0.766 
A. phagocytophilum 32 (52.5, 40.0-65.0) 1 (7.14, 0-20.6) 33 (44, 32.8-55.2) 0.002 
PCR 
Dogs with 
clinical 
leishmaniosis 
(n = 60) 
Healthy dogs 
(n = 16) 
Total dogs 
(n = 76) 
P-value 
E. canis and Anaplasma spp. 8 (13.3, 4.7-21.9) 0 (0, -) 8 (10.5, 3.6-17.4)* 0.191 
H. canis and Babesia spp. 1 (1.6, 0-4.8) 0 (0, -) 1 (1.3, 0-3.8)** 0.606 
*Only two dogs remained with a positive result after performing a conventional PCR 
and sequencing. Anaplasma platys was diagnosed. 
**Only one dog with Hepatozoon canis infection was detected. No Babesia spp. was 
detected. 
CI: confidence interval 
 
 
 
As shown in Table 2, of the 66 dogs that had a positive reaction to at least one 
pathogen, 22 seroreacted to the three pathogens assessed, 12 to E. canis and R. conorii, 
12 only to R. conorii, nine only to E. canis, six to R. conorii and A. phagocytophilum 
and finally only five dogs seroreacted only to A. phagocytophilum. 
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Fig. 1 
Number of co-infections detected by the sum of IFAT and PCR results according to dog group: healthy 
dogs (Control) or dogs with clinical leishmaniosis (Infected). A comparison of the means was performed 
with Mann-Whitney U test (P = 0.013). 
 
No statistical association was found between sex or the blood parasite load of L. 
infantum and any of the pathogens tested by IFAT. The presence of R. conorii 
antibodies was more frequent among the dogs that were older at time of diagnosis (P = 
0.0036), dogs with a lower albumin/globulin ratio (P = 0.0217; OR = 0.17) (Fig 2), dogs 
with a lower count of lymphocytes (P = 0.0309) and a high positive antibody level by 
the L. infantum quantitative ELISA (P = 0.005). The presence of E. canis antibodies 
was only associated to neutered dogs (P = 0.033) while the presence of A. 
phagocytophilum antibodies was more frequent in dogs with an increase of total protein 
(P = 0.0312; OR = 1.31), beta globulins (P = 0.0385; OR = 3.61) and gamma globulins 
(P = 0.0204; OR = 1.45), a decrease of albumin (P = 0.0017; OR = 0.24), lower 
albumin/globulin ratio (P = 0.0003; OR = 0.04) (Fig 2), a high positive antibody levels 
by the L. infantum quantitative ELISA (P = 0.003), being classified as stage III or IV of 
the LeishVet clinical staging for L. infantum (P = 0.042) (Fig 3) and being diagnosed on 
spring or winter (P = 0.014) (Fig 4). Also, a significant association was found between 
seroreactivity to R. conorii and seroreactivity to E. canis (P = 0.044; OR = 2.94) or A. 
phagocytophilum (P = 0.012; OR = 4.2), and seroreactivity to A. phagocytophilum and 
E. canis high antibody titers (P = 0.001; OR = 0). 
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No significant association was found between sex, clinical stage of leishmaniosis or the 
blood parasite load of L. infantum and the number of co-infections (both with IFAT and 
PCR). A significant association with age at time of diagnosis (P = 0.0222; cor = 
0.2791), total protein (P = 0.0373; cor = 0.2531), albumin (P = 0.0063; cor = -0.3327), 
albumin/globulin ratio (P = 0.0042; cor = -0.3588) and mean corpuscular haemoglobin 
(MCH) (P = 0.0349; cor = -0.3052) and number of co-infections detected was found by 
Spearman’s correlation. 
Of the 66 dogs that had a positive reaction to at least one pathogen, serial dilutions were 
performed and the results are listed in Table 3. 
Healthy dogs were more likely to have a negative result or to have low antibody titers 
when compared with sick dogs (Table 3). Healthy dogs were commonly negative for R. 
conorii (P = 0.025) and A. phagocytophilum (P = 0.002) antigens while they presented 
higher numbers of dogs with 1:64 positive antibody titer for E. canis (P = 0.014) when 
compared with sick dogs. 
 
Table 2 
Pattern of results of IFAT in dogs with clinical leishmaniosis and healthy dogs for one or more than one 
antigens (R. conorii, E. canis and A. phagocytophilum). Fisher’s exact test was performed. 
 
Number (%, 95% CI) of seroreactive dogs 
Antigens 
Dogs with 
clinical 
leishmaniosis 
(n = 56) 
Healthy dogs 
(n = 10) 
Total dogs 
(n = 66) 
P-value 
R. conorii alone 11 (19.64, 9.2-30.0) 1 (10, 0-28.6) 12 (18.18, 8.9-27.5) 0.675 
E. canis alone 5 (8.93, 1.4-16.4) 4 (40, 9.6-70.4) 9 (13.64, 5.3-21.9) 0.024 
A. phagocytophilum 
alone 
5 (8.93, 1.4-16.4) 0 (0, -) 5 (7.58, 1.2-14.0) 0.326 
R. conorii and 
E. canis 
8 (14.29, 5.1-23.5) 4 (40, 9.6-70.4) 12 (18.18, 8.9-27.5) 0.074 
R. conorii and 
A. phagocytophilum 
6 (10.71, 2.6-18.8) 0 (0, -) 6 (9.09, 2.1-15.9) 0.278 
E. canis and 
A. phagocytophilum 
0 (0, -) 0 (0, -) 0 (0, -) - 
R. conorii, E. canis 
and A. phagocytophilum 
21 (37.5, 24.8-50.2) 1 (10, 0-28.6) 22 (33.33, 21.9-44.7) 0.146 
CI: confidence interval 
Co-infections in dogs with clinical leishmaniosis  Marta Baxarias Canals 
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2 
The albumin/globulin ratio according 
to the result (positive or negative) of 
the different IFAT performed at a 
dilution of 1:64. A comparison of the 
means was performed with logistic 
regression with the following results: 
R. conorii (P = 0.0217; OR = 0.17), 
E. canis (P = 0.7864; OR = 0.84) and 
A. phagocytophilum (P = 0.0003; OR 
= 0.04) antigens. 
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Fig. 3 
Results of IFAT for A. phagocytophilum antigen in dogs with clinical leishmaniosis based on the 
LeishVet clinical staging. Fisher’s exact test was performed with the following result: P = 0.042*. 
 
 
 
 
Fig. 4 
Results of IFAT for A. phagocytophilum antigen in dogs with clinical leishmaniosis when grouped based 
on seasonality (time of clinical presentation) and diagnosis of leishmaniosis. Fisher’s exact test was 
performed with the following result: P = 0.014*. 
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Table 3 
IFAT antibody titers for R. conorii, E. canis and A. phagocytophilum 
antigens in dogs with clinical leishmaniosis and healthy dogs. Fisher’s 
exact test was performed. 
 
CI: confidence interval 
 
 
 
 
 
 
 
 
 
Number (%, 95% CI) of seroreactive dogs for R. conorii 
Antibody 
titers 
Dogs with 
clinical 
leishmaniosis 
(n = 61) 
Healthy dogs 
(n = 14) 
Total dogs 
(n = 75) 
P-value 
<64 15 (24.59, 13.8-35.4) 8 (57.14, 31.2-83.0) 23 (30.67, 20.3-41.1) 0.025 
64 12 (19.67, 9.7-29.7) 2 (14.29, 0-32.6) 14 (18.67, 9.9-27.5) 0.641 
128 0 (0, -) 0 (0, -) 0 (0, -) - 
256 10 (16.39, 7.1-25.7) 0 (0, -) 10 (13.33, 5.6-21.0) 0.192 
512 15 (25.59, 14.6-36.6) 4 (28.57, 4.9-52.2) 19 (25.33, 15.5-35.1) 0.743 
>512 9 (14.75, 5.8-23.6) 0 (0, -) 9 (12, 4.6-19.3) 0.195 
Number (%, 95% CI) of seroreactive dogs for E. canis 
Antibody 
titers 
Dogs with 
clinical 
leishmaniosis 
(n = 61) 
Healthy dogs 
(n = 14) 
Total dogs 
(n = 75) 
P-value 
<64 
27 (44.26, 31.8-
56.8) 
5 (35.71, 
10.6-60.8) 
32 (42.67, 31.5-
53.9) 
0.766 
64 
17 (27.87, 16.6-
39.2) 
9 (64.29, 
39.2-89.4) 
26 (34.67, 23.9-
45,5) 
0.014 
128 3 (4.92, 0-10.3) 0 (0, -) 3 (4, 0-8.4) 0.397 
256 3 (4.92, 0-10.3) 0 (0, -) 3 (4, 0-8.4) 0.397 
512 2 (3.28, 0-7.8) 0 (0, -) 2 (2.67, 0-6.4) 0.492 
1024 8 (13.11, 4.6-21.6) 0 (0, -) 8 (10.67, 3.7-17.7) 0.338 
>1024 1 (1.64, 0-4.7) 0 (0, -) 1 (1.33, 0-3.9) 0.63 
Number (%, 95% CI) of seroreactive dogs for A. phagocytophilum 
Antibody 
titers 
Dogs with 
clinical 
leishmaniosis 
(n = 61) 
Healthy dogs 
(n = 14) 
Total dogs 
(n = 75) 
P-value 
<64 
29 (47.54, 35.0-
60.0) 
13 (92.86, 79.4-
100) 
42 (56, 44.8-
67.2) 
0.002 
64 
17 (27.87, 16.6-
39.2) 
1 (7.14, 0-20.6) 
18 (24, 14.3-
33.7) 
0.165 
128 4 (6.56, 0-12.8) 0 (0, -) 4 (5.33, 0-10.4) 0.325 
256 3 (4.92, 0-10.3) 0 (0, -) 3 (4, 0-8.4) 0.397 
512 4 (6.56, 0-12.8) 0 (0, -) 4 (5.33, 0-10.4) 0.325 
1024 3 (4.92, 0-10.3) 0 (0, -) 3 (4, 0-8.4) 0.397 
>1024 1 (1.64, 0-4.7) 0 (0, -) 1 (1.33, 0-3.9) 0.63 
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No significant association was found between sex and clinical stage of leishmaniosis 
and antibody titers. A comparison between means of the different antibody titers was 
performed. The dogs that showed a high positive (>1:512) antibody titer for R. conorii 
antigen were associated with a decrease in albumin (P = 0.0113) (Fig 5) while a 
decrease of albumin/globulin ratio was associated with an increase of antibody titers for 
R. conorii antigen (P = 0.014) (Fig 6). 
 
 
Fig. 5 
Albumin concentration according to R. conorii antibody titer. A comparison of the means was performed 
with Kruskal-Wallis test (P = 0.0113). 
 
 
 
Fig. 6 
Albumin/globulin ratio according to R. conorii antibody titers. A comparison of the means was performed 
with Kruskal-Wallis test (P = 0.014). 
Co-infections in dogs with clinical leishmaniosis  Marta Baxarias Canals 
21 
 
A significant association was found between a high E. canis antibody titer and a 
decrease of albumin (P = 0.0087; OR = 0.16), albumin/globulin ratio (P = 0.0071; OR = 
0) (Fig 7), haematocrit (P = 0.0048; OR = 0.67), haemoglobin (P = 0.0053; OR = 0.57), 
RBC (P = 0.0132; OR = 0.07) and an increase of gamma globulins (P = 0.0045; OR = 
2.39) (Fig 8) and total protein (P = 0.0017; OR = 3.02). Also, a significant association 
was found between A. phagocytophilum high antibody titers and a decrease of albumin 
(P = 0.0014) and albumin/globulin ratio (P = 0.0014). 
 
Fig. 7 
Albumin/globulin ratio according to E. canis high antibody titers (equal or higher than 1:512) and low E. 
canis antibody titers (lower than 1:512). A comparison of the means was performed with logistic 
regression (P = 0.0071; OR = 0). 
 
 
Fig. 8 
Gamma globulins according to high E. canis antibodiy titers (equal or higher than 1:512) and low E. canis 
antibody titers (lower than 1:512). A comparison of the means was performed with logistic regression (P 
= 0.045; OR = 2.39). 
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PCR 
PCR for the detection of E. canis and Anaplasma spp. 
Of the 76 dogs assessed, 60 dogs with clinical leishmaniosis and 16 apparently healthy 
dogs, 8 (10.5%) had a positive result for E. canis and Anaplasma real-time PCR 
performed. All dogs with a positive result were diagnosed with clinical leishmaniosis. 
Of those 8 dogs, only two (2/8; 25%) maintained a positive result after performing a 
conventional PCR. Sequencing showed that both detected pathogens were A. platys 
(Table 4). 
When comparing between dogs with clinical leishmaniosis and healthy dogs with 
Fisher’s exact test, no difference was found between the groups. 
A significant association was found between a positive result in the real-time PCR 
performed and a lower haematocrit (P = 0.0281; OR = 0.87), RBC (P = 0.048; OR = 
0.42) and platelet (P = 0.0461; OR = 0.9) concentration. 
No significant association was found between the origin of the dogs (Barcelona or 
Tarragona) and a positive result by PCR, although the two dogs that had a positive 
result in the conventional PCR where from Tarragona. 
PCR for the detection of Hepatozoon spp. and Babesia spp. 
Of the 77 dogs assessed, only 1 (1.3%) had a positive result in the PCR performed. The 
dog was diagnosed with clinical leishmaniosis. After sequencing, the pathogen found 
was H. canis (Table 4). Babesia DNA was not detected in any of samples studied. 
No statistically significant association was found between the positive result in the PCR 
performed and any of the clinical characteristics of the dogs assessed. 
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Table 4 
Dogs which had a positive result in the PCRs performed and the corresponding results for IFAT for different antigens studied. 
 
Dog 
ID 
IFAT 
R. conorii 
IFAT 
E. canis 
IFAT 
A. phagocytophilum 
Real-time PCR 
Ehrlichia/Anaplasma 
Conventional PCR 
Ehrlichia/Anaplasma 
PCR 
Hepatozoon/Babesia 
Sequencing 
HCV-7 512 1024 1024 Positive Negative Negative - 
HCV-9 <64 <64 <64 Positive Negative Negative - 
HCV-11 >512 <64 64 Positive Negative Negative - 
HCV-28 512 1024 256 Positive Negative Negative - 
HCV-31 64 64 128 Positive Negative Negative - 
MO-1 512 128 64 Positive Positive Negative A. platys (99%) 
MO-4 256 64 1024 Negative - Positive H. canis (100%) 
MED-5 64 <64 <64 Positive Positive Negative A. platys (100%) 
MED-7 <64 <64 1024 Positive Negative Negative - 
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5. Discussion 
Previous studies have speculated about how CanL could be affected by other vector-
borne pathogens. De Tommasi et al. (2013) stated that an infection with two or more 
pathogens could complicate the clinical presentation of the diseases and the severity of 
haematological abnormalities in dogs and Mekuzas et al. (2009) examined naturally 
exposed dogs with L. infantum and E. canis co-infection and described that the increase 
of clinical signs could support the postulation of a synergistic pathological effect 
between both pathogens. Furthermore, Mekuzas et al. (2009) suggested that E. canis 
could be contributing to the establishment of CanL and Baneth et al. (2015) examined 
three dogs with E. canis and H. canis co-infection and suggested that infection with one 
pathogen could permit or enhance invasion of another. Conversely, Tabar et al. (2013) 
examined dogs with leishmaniosis and/or filariosis to detect filarial species, Wolbachia 
species and Leishmania and, although an increase of severity and clinical signs was 
observed when Leishmania-filarial co-infection, it was also suggested that Wolbachia 
infection could have a protective role against Leishmania infection. 
Our results demonstrated the existence of co-infections with vector-borne pathogens in 
dogs with clinical leishmaniosis living in the Mediterranean basin. To the best 
knowledge of the authors, a statistical significant relationship was found, for the first 
time, between sick dogs and a higher number of detected co-infections and the detection 
of R. conorii or A. phagocytophilum antibodies when compared with healthy dogs. 
Accordingly, a recent study documented that co-infection with several tick-borne 
diseases caused clinical progressions of leishmaniosis in foxhounds living in the USA 
(Toepp et al. 2017). In disagreement with previous reports (Mekuzas et al. 2009; De 
Tommasi et al. 2013; Estevez et al. 2017; Lima et al. 2017; Rodriguez Sánchez et al. 
2017), no association was found between seroreactivity to E. canis antigens and sick 
dogs with leishmaniosis. 
One of the more interesting findings in the present study is the fact that more 
pronounced clinicopathological abnormalities such as decrease in albumin or RBC 
numbers or increase in globulins were noted in dogs with clinical leishmaniosis and co-
infections. Similar findings were previously reported by other studies. These studies 
demonstrated more marked thrombocytopenia, an evident reduction of platelet 
aggregation response, a significant increase in activated partial thromboplastin time 
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(APTT) and a reduction of the albumin/globulin ratio in Italian dogs with clinical 
leishmaniosis co-infected with E. canis (Cortese et al. 2006; Cortese et al. 2009; Cortese 
et al. 2011). Here, in the present study, we reported for the first time that certain 
clinicopathological abnormalities are more marked in dogs with co-infections with R. 
conorii, or Rickettsia related species, A. platys, E. canis and H. canis. It is important to 
highlight that based on the present findings, moderate to marked hypoalbuminemia or 
hyperglobulinemia in dogs with clinical leishmaniosis should be very suspicious of co-
infections with other vector-borne pathogens. It is well known that infection with tick-
borne pathogens such as R. conorii, A. platys, A. phagocytophilum and E. canis may 
induce a decrease in serum levels of negative acute phase proteins while and increase of 
positive acute phase proteins occurs in canines with these infections (Kohn et al. 2008; 
Al Izzi et al. 2013; Dondi et al. 2014; Solano-Gallego et al. 2015; Bouzouraa et al. 
2016). Interestingly, an association was found between antibodies against A. 
phagocytophilum and more advanced clinical stages of leishmaniosis (Leishvet stage III 
and IV) in agreement with the recent previous study (Toepp et al. 2017). Moreover, a 
significant association was also found between dogs positive for E. canis and 
Anaplasma spp. PCR and a lower haematocrit, RBC and platelets, which are typical 
clinicopathological findings in canine ehrlichiosis or anaplasmosis (Little 2010; 
Procajło et al. 2011; Dondi et al. 2014; Pantchev et al. 2015). Further studies are needed 
to understand the relationship between co-infections and clinical leishmaniosis in dogs. 
Previous studies have evaluated the serological and molecular evidence of exposure to 
vector-borne pathogens in dogs in Catalonia (Spain) (Roura et al. 2005; Solano-Gallego 
et al. 2006; Tabar et al. 2009; Miró et al. 2013). Taking these studies into account, our 
results demonstrated a high increase of seropositivity rates when studying dogs with 
clinical leishmaniosis. Another study done by Amusategui et al. (2008) in North-
western Spain found similar seroprevalences as the ones found in this study: 50% for R. 
conorii, 54.7% for E. canis and 45.3% for A. phagocytophilum antigens. The difference 
is that those seroprevalences were found in dogs living in community dog shelters, not 
in sick dogs with clinical leishmaniosis. In this same study, it was reported that the 
seroprevalence of E. canis and A. phagocytophilum was higher in dogs in a community 
shelter than in dogs evaluated at local veterinary clinics (Amusategui et al. 2008). 
Another important point is the results obtained by the PCRs performed in this study. 
Tabar et al. (2009) examined 153 dogs and found the following percentages of infection 
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by blood PCR. Four per cent for Ehrlichia spp. and Anaplasma spp., 3.3% for H. canis 
and 2% for B. vogeli. In the present study, eight dogs (10.7%) had a positive PCR result 
for E. canis and Anaplasma spp. and only two of them remained positive by 
conventional PCR confirming A. platys infection in both cases. Hepatozoon canis was 
only found in one sick dog with leishmaniosis while Babesia DNA was not detected in 
any of the dogs studied in agreement with previous studies performed in Sicily (Italy) 
although B. vogeli was encountered in febrile Sicilian dogs (Solano-Gallego et al. 
2015). Combining the serological and molecular results of the present study with the 
present literature, it is noteworthy to remark that co-infections patterns will be different 
depending on the geographical region where the dogs with leishmaniosis live, their life 
style, their exposure to ticks and fleas, the species of ectoparasites present in the area, 
and also on the preventative measures applied against ticks and fleas. For example, in 
the present study, A. platys and H. canis were only confirmed by PCR in dogs from the 
Tarragona area. In the Mediterranean basin, where R. sanguineus ticks are common, it 
would be expected that the pathogens related to these ticks would be also prevalent 
(Beugnet and Marié 2009; Hornok et al. 2017), however, comparing the present study 
with other recent studies from Croatia (Mrljak et al. 2017), Greece (Latrofa et al. 2017), 
Cyprus (Attipa et al. 2017) and Israel (Azmi et al. 2017), it is evident that E. canis, 
Hepatozoon spp. and Babesia spp. are circulating abundantly in those countries while, 
in the Spanish regions studied in this present study, the results suggest that they are less 
common. 
Moreover, it is noteworthy to take into account the difference of the diagnostic 
techniques used in this study. PCR is a technique that can detect pathogen DNA and, 
therefore, confirm infection but a negative result does not completely exclude infection 
while serology techniques, as ELISA or IFAT, can detect antibodies, which could be 
interpreted as current infection, past exposure to the pathogen tested or be used to detect 
seroconversion, but may also be the result of cross-reaction with antibodies formed 
against other organisms with similar antigens. PCR also allows speciation of DNA of 
the pathogen amplified. Due to the aforementioned characteristics, it is recommended to 
use both techniques for diagnosis (Tabar et al. 2009; Nicholson et al. 2010; Otranto et 
al. 2010). In the present study, the results found for the different PCR performed 
showed an important limitation in the detection of  positive samples, possibly due to the 
low concentration of pathogen in blood. It is important to remark that with these type of 
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pathogens, serial evaluations of blood parasitemia by PCR are recommended to enhance 
the likelihood of PCR detection (Kidd et al. 2017). Additionally, in this case, no 
repeated testing of the same dogs was performed and serology was not used to detect 
seroconversion, although seroconversion could have been helpful in the detection of a 
higher number of acute infections (Solano-Gallego et al. 2015; Kidd et al. 2017). 
Furthermore, in the present study, no PCR was performed to detect Rickettsia spp. such 
as R. conorii due to the low rickettsiemia usually found in dogs (Solano-Gallego et al. 
2008; Tabar et al. 2009; Solano-Gallego et al. 2015). 
Another important point to consider would be the different cross-reactions that could 
have occurred in this study. It has been reported that many of the reactions made in 
serological tests for R. conorii might be due to other spotted fever group (SFG) 
Rickettsia species as R. massiliae, R. slovaca or R. aeschlimannii among others, which 
are more common in ticks in the Mediterranean basin countries (Merino et al. 2005; 
Fernández-Soto et al. 2006; Solano-Gallego et al. 2015). Furthermore, 
serocrossreactivity between A. phagocytophilum and A. platys is common, and at 
similar antibody titration, due to their high antigenic similarity (Aguirre et al. 2006; 
Miró et al. 2013; Estrada-Peña et al. 2017). In Europe, A. phagocytophilum is usually 
transmitted by I. ricinus ticks while A. platys is suspected as transmitted by R. 
sanguineus (Beugnet and Marié 2009; Little 2010; Chomel 2011). Taking into account 
that the main tick that inhabits the Barcelona area is R. sanguineus (Estrada-Peña et al. 
2004), it can be suggested that the positive serologic reactivity was probably aimed at A. 
platys and not A. phagocytophilum. In similar way, E. canis can also have a serocross-
reaction with Anaplasma species (Waner et al. 2001; Gaunt et al. 2010). In the present 
study, 22 dogs seroreacted to both, E. canis and A. phagocytophilum, and without a 
positive result by PCR and sequencing, it could be suggested that the dogs were 
exposed to only one of the two vector-borne pathogens detected and, actually, they 
could have been infected by A. platys, the only Anaplasmataceae species detected by 
PCR. 
Another finding of the present study was the detection of a higher number of pathogens 
by IFAT and PCR in older dogs compared to young dogs. It is reasonable that an older 
dog would have had more time and opportunities to be exposed to the different 
pathogens studied, although young dogs could be more susceptible to infections due to 
the immaturity of the immune system (Greeley et al. 2001; Blount et al. 2005; Day 
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2007; Day 2010). In agreement, Amusategui et al. (2008) stated that R. conorii infection 
was significantly associated with older age. But, a recent study (Santana Almeida et al. 
2017) found that young animals are more susceptible to co-infection of Leishmania and 
Babesia spp. and Miró et al. (2013) found that dogs under one year of age showed 
higher seropositivity rates for E. canis and Borrelia Burgdorferi compared to dogs older 
than one year. Further studies need to be performed to understand the relationship 
between age and vector-borne diseases, taking into account other factors such as 
lifestyle and location. 
When studying vector-borne pathogens, it is also expected to find a relationship 
between the time of the detection of the infection and the season when the vector is 
more active. In this study, only the results of IFAT for A. phagocytophilum antigen 
showed an association between seropositivity and season, in this case spring or winter. 
The vectors for A. phagocytophilum present in Spain is I. ricinus (Beugnet and Marié 
2009; Little 2010; Chomel 2011), which have the highest activity between April and 
June, a decrease of activity thereafter and a slight increase in the autumn-winter months 
(Barandika et al. 2011). When evaluating our results, it could be suggested that the dogs 
with a positive IFAT result for A. phagocytophilum antigen were infested with these 
ticks and a subsequent infection occurred. However, we have suggested earlier in this 
study, antibodies against A. phagocytophilum are likely to be antibodies against A. 
platys, and, as mentioned above, the main vector for this pathogen is probably R. 
sanguineus. Different studies (Lorusso et al. 2010; Dantas-Torres et al. 2011) have 
evaluated the seasonal dynamics of this tick in the Mediterranean basin and, although it 
has been stated that the highest activity of R. sanguineus is in summer, it has also been 
observed that this tick can infest dogs during all seasons. Furthermore, A. platys is 
known to cause subclinical infections (Bradfield et al. 1996; Little 2010; Bouzouraa et 
al. 2016) and, in fact, that the detection of the infection might not be associated with the 
season. On the other hand, no association was found between the other vector-borne 
pathogens and seasonality. This could be due to the high probability of subclinical and 
chronic ehrlichiosis during canine infection with E. canis (Little 2010) with the 
consequent delay in detection of infection as well as with leishmaniosis (Baneth et al. 
2008; Solano-Gallego et al. 2009; Pennisi 2015). Rickettsia conorii infection in dogs is 
also typically a subclinical or mild disease (Solano-Gallego et al. 2015). 
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A number of limitations are present in this study due to its retrospective nature. It would 
be interesting to increase the spectrum of clinical stages in the dogs with clinical 
leishmaniosis as the majority of them were classified as being in stage II of the 
LeishVet clinical staging, and also to increase the numbers of dogs both sick and 
apparently healthy dogs included in the study. Another limitation, that was found when 
analysing the data, was the lack of information about the lifestyle of the dogs. It would 
be highly important to know if they were living indoors or outdoors and therefore how 
much exposure did they have to sand flies and ticks. Moreover, the use of serial testing 
to detect seroconversion and associate the results with changes in the clinical signs and 
clinicopathological findings would be also interesting to evaluate. In addition, it could 
be suggested to increase the number of pathogens tested and include other canine 
pathogens such as Bartonella spp. which may also be encountered in Spain (Roura et al. 
2005; Solano-Gallego et al. 2006; Amusategui et al. 2008; Tabar et al. 2009; Miró et al. 
2013). Future studies should be designed as case control longitudinal studies to obtain 
additional information on vector-borne diseases and their co-infections in Spain. 
 
6. Conclusion 
This study demonstrates that dogs with clinical leishmaniosis from the Barcelona and 
Tarragona area have a higher rate of co-infections with other vector-borne pathogens 
when compared with healthy controls. Furthermore, positivity to other vector-borne 
pathogens was associated with more pronounced clinicopathological abnormalities as 
well as disease severity with canine clinical leishmaniosis. 
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9. Annexes 
Annex 1. LeishVet Clinical Staging (Solano-Gallego et al. 2009; Solano-gallego et al. 2011) 
Clinical stages Serology Clinical signs Laboratory findings Therapy Prognosis 
Stage I 
Mild 
disease 
Negative to low 
positive 
antibody levels 
Dogs with mild clinical signs such as 
peripheral lymphadenomegaly, 
or papular dermatitis 
Usually no clinicopathological 
abnormalities observed. 
Normal renal profile: creatinine < 1.4 mg/dl; 
non-proteinuric: UPC < 0.5 
Scientific neglect/allopurinol or 
meglumine antimoniate or  
miltefosine/allopurinol + 
meglumine antimoniate or 
allopurinol + miltefosine** 
Good 
Stage II 
Moderate 
disease 
Low to high positive 
antibody levels 
Dogs, which apart from the signs listed 
in stage I, may present: diffuse or 
symmetrical cutaneous lesions such as 
exfoliative dermatitis/onychogryposis, 
ulcerations (planum nasale, footpads, 
bony prominences, mucocutaneous 
junctions), anorexia, weight loss, 
fever, and epistaxis 
Clinicopathological abnormalities such as mild 
non-regenerative anaemia, hyperglobulinemia, 
hypoalbuminemia, serum hyperviscosity 
syndrome. 
Substages 
a) Normal renal profile: creatinine < 1.4 mg/dl; 
non-proteinuric: UPC < 0.5 
b) Creatinine < 1.4 mg/dl; UPC = 0.5-1 
Allopurinol + meglumine 
antimoniate or allopurinol + 
miltefosine 
Good 
to 
guarded 
Stage III 
Severe 
disease 
Medium to high 
positive 
antibody levels 
Dogs, which apart from the signs listed 
in stages I and II, may present signs 
originating from immune-complex 
lesions: 
vasculitis, arthritis, uveitis and 
glomerulonephritis 
Clinicopathological abnormalities listed in stage 
II. 
Chronic kidney disease (CKD) IRIS stage I with 
UPC > 1 or stage II (creatinine 1.4-2 mg/dl) 
Allopurinol + meglumine 
antimoniate or allopurinol + 
miltefosine 
Follow IRIS guideline for 
CKD. 
Guarded 
to 
poor 
Stage IV 
Very severe 
disease 
Medium to high 
positive 
antibody levels 
Dogs with clinical signs  
listed in stage III.  
Pulmonary thromboembolism, or 
nephrotic syndrome and end stage 
renal disease 
Clinicopathological abnormalities listed in stage II 
CKD IRIS stage III (creatinine 2-5 mg/dl) and 
stage IV (creatinine > 5 mg/dl). Nephrotic 
syndrome marked proteinuria UPC > 5 
Allopurinol (alone) 
Follow IRIS guidelines for 
CKD 
Poor 
